Chronic hypertension screening: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) |
||
| Line 3: | Line 3: | ||
{{CMG}}: {{AE}} {{AN}} | {{CMG}}: {{AE}} {{AN}} | ||
==Overview== | ==Overview== | ||
The Joint National Committee seventh report (JNC 7) defines hypertension as a [[systolic blood pressure]] of over 140 mm Hg or a [[diastolic blood pressure]] greater than 90 mm Hg based upon the average of two or more properly measured readings at each of two or more visits after an initial screen<ref name="pmid12748199">{{cite journal| author=Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al.| title=The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. | journal=JAMA | year= 2003 | volume= 289 | issue= 19 | pages= 2560-72 | pmid=12748199 | doi=10.1001/jama.289.19.2560 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12748199}}</ref>. The | The Joint National Committee seventh report (JNC 7) defines hypertension as a [[systolic blood pressure]] of over 140 mm Hg or a [[diastolic blood pressure]] greater than 90 mm Hg based upon the average of two or more properly measured readings at each of two or more visits after an initial screen<ref name="pmid12748199">{{cite journal| author=Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al.| title=The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. | journal=JAMA | year= 2003 | volume= 289 | issue= 19 | pages= 2560-72 | pmid=12748199 | doi=10.1001/jama.289.19.2560 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12748199}}</ref>. The ''Systematic Review of Guidelines on Cardiovascular Risk Assessment'' in 2010 noted two hypertension screening guidelines for adults published by the U.S. Preventive Services Task Force (USPSTF) and American Heart Association (AHA).<ref name="pmid20065196">{{cite journal| author=Ferket BS, Colkesen EB, Visser JJ, Spronk S, Kraaijenhagen RA, Steyerberg EW et al.| title=Systematic review of guidelines on cardiovascular risk assessment: Which recommendations should clinicians follow for a cardiovascular health check? | journal=Arch Intern Med | year= 2010 | volume= 170 | issue= 1 | pages= 27-40 | pmid=20065196 | doi=10.1001/archinternmed.2009.434 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20065196 }} </ref> | ||
==Screening== | ==Screening== | ||
Revision as of 17:44, 9 March 2013
|
Hypertension Main page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]: Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]
Overview
The Joint National Committee seventh report (JNC 7) defines hypertension as a systolic blood pressure of over 140 mm Hg or a diastolic blood pressure greater than 90 mm Hg based upon the average of two or more properly measured readings at each of two or more visits after an initial screen[1]. The Systematic Review of Guidelines on Cardiovascular Risk Assessment in 2010 noted two hypertension screening guidelines for adults published by the U.S. Preventive Services Task Force (USPSTF) and American Heart Association (AHA).[2]
Screening
Screening Test[1]
| Diagnosis | Diagnostic Tests |
| Chronic kidney disease | Estimate GFR |
| Coarctation of aorta | CT angiography |
| Cushing's syndrome and other glucocorticoid excess states including chronic steroid therapy | History; dexamethasone suppression test |
| Drug induced/related | History; drug screening |
| Pheochromocytoma | 24 hour urinary metanephrine and normetanephrine |
| Primary aldosteronism and other mineralocorticoid 24-hour urinary aldosterone level or excess states | 24-hour urinary aldosterone level or specific measurements of other mineralocorticoids |
| Renovascular hypertension | Doppler flow study; magnetic resonance angiography |
| Sleep apnea | Sleep study with O2 saturation |
| Thyroid/ Parathyroid disease | TSH; serum PTH |
References
- ↑ 1.0 1.1 Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL; et al. (2003). "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report". JAMA. 289 (19): 2560–72. doi:10.1001/jama.289.19.2560. PMID 12748199.
- ↑ Ferket BS, Colkesen EB, Visser JJ, Spronk S, Kraaijenhagen RA, Steyerberg EW; et al. (2010). "Systematic review of guidelines on cardiovascular risk assessment: Which recommendations should clinicians follow for a cardiovascular health check?". Arch Intern Med. 170 (1): 27–40. doi:10.1001/archinternmed.2009.434. PMID 20065196.